Regadenoson Anhydrous: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Regadenoson Anhydrous. Educational only — not medical advice.
Labeled uses
LEXISCAN® (regadenoson) injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress.
Source: FDA labeling via NIH DailyMed (set 99640071…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.